Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
04/27/1994 | EP0594257A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
04/27/1994 | EP0594101A1 A process for the preparation of diltiazem |
04/27/1994 | EP0594099A1 Process for the purification of crude clavulanic acid |
04/27/1994 | EP0594022A1 Alkoxymethyl substituted pyridinone-biphenyls as angiotensin II antagonists |
04/27/1994 | EP0594019A1 Trisubstituted biphenyl as angiotensin II antagonistes |
04/27/1994 | EP0594001A1 Pyrazolo 4,3-c pyridines, a process for their preparation and their use as serotonin reuptake inhibitors |
04/27/1994 | EP0594000A1 Substituted (pyridinylamino)-benzisoxazoles and benzoisothiazole a process for their preparation and their use as medicaments |
04/27/1994 | EP0593976A1 Crystalline (R)-(-)-2-cycloheptyl-N-methylsulfonyl-4-(2-quinolinyl-methoxy)-phenyl-acetamide |
04/27/1994 | EP0593901A2 Oligoribonucleotide- and ribozyme-analoguer with terminal 3',3'- and 5',5'-bonds respectively |
04/27/1994 | EP0593897A1 Stabilized solutions of alkylphosphocholine in glycerolalkylether |
04/27/1994 | EP0593831A1 Long-chain fatty alcohols as neurotrophic and memory improving agents |
04/27/1994 | EP0593807A1 Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
04/27/1994 | EP0593774A1 Food composition which inhibits formation of intestinal putrefaction product |
04/27/1994 | EP0593766A1 Pyridonecarboxylic acid derivative |
04/27/1994 | EP0593761A1 New thiophene derivatives |
04/27/1994 | EP0593692A1 Process for the preparation of ergoline derivatives |
04/27/1994 | EP0593663A1 Method and assay system for neurotrophin activity |
04/27/1994 | EP0593658A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
04/27/1994 | EP0593639A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same. |
04/27/1994 | EP0593633A1 Metabolizable plasma substitute |
04/27/1994 | EP0593603A1 Bicyclic fibrinogen antagonists |
04/27/1994 | EP0593601A1 Novel compositions based on taxane class derivatives |
04/27/1994 | EP0593595A1 Derivatives of inositol, preparations containing them and their use |
04/27/1994 | EP0593590A1 Pharmaceutical preparation for peritoneal dialysis. |
04/27/1994 | EP0593573A1 Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof |
04/27/1994 | EP0593562A1 Tropical composition containing penciclovir |
04/27/1994 | EP0593559A1 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
04/27/1994 | EP0593536A1 DIBENZ b,e]AZEPINE DERIVATIVES AND DRUGS CONTAINING THEM |
04/27/1994 | EP0593520A1 Ocular compositions containing steroids and their use in treating glaucoma |
04/27/1994 | EP0593513A1 Tryptamine analogues, their synthesis and their use as 5-ht1-like receptors or 5-ht2 receptor agonistes |
04/27/1994 | EP0593511A1 Piperidine derivates having anxiolytic effect |
04/27/1994 | EP0593464A1 BENZOIC ACID DERIVATIVES and their use as LTB4 inhibitors |
04/27/1994 | EP0593463A1 Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
04/27/1994 | EP0593461A1 3-substituted-1-(aryl or arylalkyl)-2(1h)-quinolinones |
04/27/1994 | EP0593457A1 Antimicrobial quinolone thioureas |
04/27/1994 | EP0593418A1 Alkali and alkaline earth salts of oxypurinol in amorphous or crystalline form as agents for treating hyperuricemia and gout. |
04/27/1994 | EP0505565B1 Quinoline derivatives, their production and use |
04/27/1994 | EP0462145B1 Covalent conjugates of lipid and oligonucleotide |
04/27/1994 | EP0460034B1 Novel vitamin d analogues |
04/27/1994 | EP0460032B1 Novel vitamin d analogues |
04/27/1994 | EP0422097B1 Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
04/27/1994 | EP0408546B1 Improvements relating to drug delivery systems |
04/27/1994 | EP0345294B1 Drugs containing platinum complexes |
04/27/1994 | CN1085948A Method for prepn. of wine made of Amorphophallus rivieri |
04/27/1994 | CN1085909A Novel quaternary nitrogen containing phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
04/27/1994 | CN1085908A Liponucleotides of seco-nucleosides, processes for the preparation thereof and pharmaceutical compositions with antiviral action containing them |
04/27/1994 | CN1085907A Novel thio-substituted, nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
04/27/1994 | CN1085906A Novel quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
04/27/1994 | CN1085903A Pharmaceutical compounds |
04/27/1994 | CN1085901A Heterocyclic compounds |
04/27/1994 | CN1085899A 7-(2-aminoethyl)-benzothiazolones |
04/27/1994 | CN1085898A Branched alkylamino derivatives of thiazole, processes for preparing them and pharmaceutical compositions containing them |
04/27/1994 | CN1085897A Angiotension II antagonists |
04/27/1994 | CN1085896A Angiotensin II antagonist imidazole derivatives, their preparation and their theapeutic use |
04/27/1994 | CN1085894A Antiinflammatory indolinyl N-hydroxyurea and N-hydroxamic acid derivatives |
04/27/1994 | CN1085794A Capsule for curing hepatitis |
04/27/1994 | CN1085779A Method for prodn. of medicinal prepns. for eyes |
04/27/1994 | CN1085778A Smoothing cleaning agent for women use |
04/27/1994 | CN1085777A Pellet of aspirin with small fixed dosage |
04/27/1994 | CN1024347C Prepn. of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains |
04/27/1994 | CN1024346C Antihypertensive 3-piperidinyl-indazole derivatives |
04/27/1994 | CN1024345C Process for preparing cycloalkanylpyrrole |
04/27/1994 | CA2109019A1 Method of disinfecting a contact lens and preserving a contact lens care solution |
04/26/1994 | US5306841 A phosphates, phosphites or phosphinates acyloxyalkyl; a nutrients for animals |
04/26/1994 | US5306837 Antiviral agents |
04/26/1994 | US5306822 Mono-, di- or tri-methoxyphenylmethylene-2-thioxo-4-oxazolidinone as antihistamines |
04/26/1994 | US5306820 Process for the preparation of enantiomerically pure substituted (quinolin-2-yl-methoxy)phenylacetic acids |
04/26/1994 | US5306818 Treating degenerative diseases such as emphysema, rheumatoid arthritis and pancreatitis |
04/26/1994 | US5306817 Process for the stereospecific synthesis of azetidinones |
04/26/1994 | US5306816 Processes for preparing carbapenem derivatives |
04/26/1994 | US5306809 Acid-labile linker molecules |
04/26/1994 | US5306732 Administering vinigrol |
04/26/1994 | US5306731 Method and products for treating the eye |
04/26/1994 | US5306730 Botulinum toxin neutralizer |
04/26/1994 | US5306729 Method for effecting vasodilation with monoglycerides |
04/26/1994 | US5306727 Selectively cytotoxic in hypoxic cells |
04/26/1994 | US5306726 Antidiabetic agents |
04/26/1994 | US5306724 Administering L-2-oxothiazolidine-4-carboxylic acid to stimulate intracellular synthesis of glutathione |
04/26/1994 | US5306723 A racemic optical compound for treating central nervous system is also an antihypertensive agent |
04/26/1994 | US5306722 Thymidine derivatives and therapeutic method of use |
04/26/1994 | US5306720 Treatment of cerebrovascular disorders |
04/26/1994 | US5306719 Carbostyril derivatives and salts thereof |
04/26/1994 | US5306718 Analgesics, cognition activators |
04/26/1994 | US5306717 Cephalosporin derivatives |
04/26/1994 | US5306716 Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds |
04/26/1994 | US5306715 Storage stability |
04/26/1994 | US5306714 (S)-2,3-dihydropolyprenyl, monophosphate, and agents for inhibiting the metastasis of cancers |
04/26/1994 | US5306713 Highly active antioxidant of tocopheryl ascorbyl phosphate |
04/26/1994 | US5306711 A preservatives comprising a low molecular weight of dextran; free of necrosis |
04/26/1994 | US5306508 Red blood cell surrogate |
04/26/1994 | US5306507 The particles has outer coatings, cores separated by a solid intermediate layer containing pregelatinized starch to separate the two maleates; tablets |
04/26/1994 | US5306503 Patch with a high content of softening ingredients |
04/26/1994 | US5306492 Oligosaccharide conjugated to carrier protein |
04/26/1994 | US5306490 Methods for retarding blister formation by use of cyanoacrylate adhesives |
04/26/1994 | US5306482 Benz(alk or eth)orium chloride |
04/26/1994 | CA1328878C Antihypercholesterolemic agents |
04/26/1994 | CA1328877C Antihypercholesterolemic agents |
04/26/1994 | CA1328876C 5-oxygenated hmg-coa reductase inhibitors |
04/26/1994 | CA1328875C N-substituted amide derivatives |
04/26/1994 | CA1328873C Hypoglycemic thiazolidinedione derivatives |